ALM Drug Therapy to reduce inflammation and scar formation after ACL reconstruction surgery: Targeting earlier return to active duty. (Old ID 26666)

United States Department of Defence
Jodie Morris
Role

Chief Investigator

Description

Two complications of anterior cruciate ligament (ACL) reconstruction surgery are cartilage degeneration and scarring within the joint, which can prolong healing, promote pain and restrict knee movement. Our project will evaluate a new therapy known as ALM solution that can be administrered during ACL reconstruction surgery to dampen inflammation, protect cartilage and promote tissue healing within the joint. Our study has the potential to expedite a patient's return to an active duty with fewer complications.

Date

30 Sep 2020 - 29 Sep 2024

Project Type

GRANT

Keywords

ACL Injury;ACL Reconstruction surgery;Scarring;Osteoarthritis;Inflammation;Therapeutics

Funding Body

United States Department of Defence

Amount

1061864.32

Project Team

Peter McEwen;Erik Biros;Jodie Morris;Hayley Letson